Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is one of the leading causes of cancer-related deaths worldwide. Regorafenib, a multi-kinase inhibitor, is used as a second-line treatment for advanced HCC. Here, we aimed to investigate the mechanism of the antitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Takuma, Kei, Fujihara, Shintaro, Fujita, Koji, Iwama, Hisakazu, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Mimura, Shima, Tani, Joji, Shi, Tingting, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835935/
https://www.ncbi.nlm.nih.gov/pubmed/35163589
http://dx.doi.org/10.3390/ijms23031667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835935/
https://www.ncbi.nlm.nih.gov/pubmed/35163589
http://dx.doi.org/10.3390/ijms23031667

Ejemplares similares